Netherlands· NL-5bd3e3df4421
Irbesartan/hydrochloorthiazide Xiromed 300 mg/12,5 mg tabletten
A irbesartan und diuretika product containing hydrochloorthiazide + irbesartan, registered in Netherlands by Medical Valley Invest AB. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Irbesartan und diuretika is registered in 13 of 19 countries.
Countries holding a registration under ATC C09DA04 (irbesartan und diuretika), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Irbesartan und diuretika · ATC C09DA04
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCHLOORTHIAZIDE + IRBESARTAN
- Manufacturer
- Medical Valley Invest AB
- Country
- Netherlands (NL)
- ATC code
- C09DA04
- ATC class
- Irbesartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id104726
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for irbesartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Irbesartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DA04
Irbesartan und diuretika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e38e1ce7-8ca1-4ba9-9e0e-50c35f28e16d GET /v1/drugs/e38e1ce7-8ca1-4ba9-9e0e-50c35f28e16d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h104726_smpc.pdf",
"strength": null,
"atc_label": "Irbesartan And Diuretics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg104726",
"excipients": [
"CASTOROLIE, GEHYDROGENEERD",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"POVIDON (E 1201)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"HYDROCHLOORTHIAZIDE",
"IRBESARTAN"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h104726.pdf",
"authorised_at": "2011/02/16",
"procedure_number": "NL/H/1680/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "104726",
"additional_monitoring": "N"
}See everything about irbesartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.